ArticleBMJ case reports2021

Triple therapy with adalimumab, ustekinumab and methotrexate for induction of remission in moderate to severe ileocolonic Crohn's disease with upper gastrointestinal involvement in a biologic-experienced individual.

Na Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.